ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,137, issued on Aug. 5, was assigned to MEDY-TOX INC. (Suwon-si, South Korea).
"Long lasting effect of new botulinum toxin formulations" was invented by Hyun Ho Jung (Seoul, South Korea), Gi Hyeok Yang (Cheonan-si, South Korea), Hyun Jee Kim (Asan-si, South Korea) and Chang Hoon Rhee (Seoul, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the use of an animal-protein-free botulinum toxin composition to treat a disease, disorder or condition in a patient in need thereof whereby the animal-protein-free botulinum toxin composition exhibits a longer lasting effect in the patient compared to an animal-protein-containing ...